Carlos Pedraza
Company: Alkermes
Job title: Director of CNS Biology
Seminars:
Live Speaker Q&A 5:20 pm
day: Day Two
Developing Remyelination Therapies for Neurodegenerative Diseases 3:40 pm
• Myelin degeneration and/or dysregulation is a common characteristic of neurodegenerative and neuropsychiatric diseases • Remyelination and neuroprotection therapies are the next frontier in drug development for neuroimmune and neurodegenerative pathologies • How can we develop novel methodologies and medications to promote remyelination and repair of the affected nerve cells? • How can we best…Read more
day: Day Two